About Phathom Pharma (PHAT)
Phathom Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing treatments for gastrointestinal (GI) diseases. Its product candidate, vonoprazan, is an oral small molecule pot... Read more
- USD9.04
- USD9.14
- USD8.29
- USD19.71
- -14.80%
- 82M
- 882.68k
- 3.63M
- 641M
- 2.21
- -22.20%
Stock News
1 hour ago
S&P 500 stumbles after hitting intraday high — the downside of a narrow rally
MarketWatch
2 hours ago
Amazon turns to rival SpaceX to launch next batch of Kuiper internet satellites
CNBC
3 hours ago
GM expands production of gas-powered SUV, trucks in Michigan
CNBC
3 hours ago
Trump's new trade deal promises billions to the U.S. — plus, reasons behind the mixed market
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
